Jafarnezhad-Ansariha, Fahimeh <br/><br/>
The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.  [electronic resource] 

 -  Inflammopharmacology  Apr 2018 
 - 375-384 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1568-5608 
<br/><br/><label>Standard No.: </label>10.1007/s10787-017-0386-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Cell Line<br/>Cyclooxygenase 1--metabolism<br/>Cyclooxygenase 2--metabolism<br/>Female<br/>Gene Expression--drug effects<br/>Hexuronic Acids--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Inflammation--drug therapy<br/>Iran<br/>Macrophages--drug effects<br/>Male<br/>Mice<br/>Monocytes--drug effects<br/>Spondylitis, Ankylosing--drug therapy